← All stocks

Oruka Therapeutics, Inc.

ORKA Mostly scheduled

CIK 0000907654 #1126 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$10.21M

$53.60K on a plan · $9.74M straight out of an exercise

Sold at will

$420.84K

3 of 22 sales

Net

−$10.21M

−$420.84K against sales at will

By person

9 insiders · 22 transactions

141×

Lawrence Klein holds 141 times base salary in stock. $88.35M of shares against $624.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Lawrence Klein last reported holding, valued at $95.71, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Klein Lawrence Otto

Chief Executive Officer

—

$7.12M (4) scheduled

−$7.12M

923,128

1.39%

$88.35M

+8.3%

Goncalves Joana

Chief Medical Officer

—

$1.52M (9) scheduled

−$1.52M

31,771

0.0480%

$3.04M

+1,659%

Agarwal Arjun

Senior Vice President, Finance

—

$926.01K (5) scheduled

−$926.01K

14,752

0.0223%

$1.41M

+457.5%

Sandler Laura Lee

Chief Operating Officer

—

$545.81K (3) scheduled

−$545.81K

235,478

0.3557%

$22.54M

+10.5%

Quinlan Paul T

General Counsel

—

$99.44K (1)

−$99.44K

29,995

0.0453%

$2.87M

—

Venrock Healthcare Capital Partners III, L.P. entity

10% owner

—

4,148,428

6.27%

$397.05M

+3.1%

Fairmount Funds Management LLC entity

Director

—

1,131,954

1.71%

$108.34M

+77.3%

Edwards Larry Todd

Chief Commercial Officer

—

100,000

0.1510%

$9.57M

—

Dambkowski Carl

Director

—

38,743

0.0585%

$3.71M

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Agarwal Arjun

15 Sep 2026

Senior Vice President, Finance

Sold on a plan

560

$95.71

$53.60K

Show all 22 transactions →

What was left out

Form 4 filings counted 9

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 1

Sales straight out of an exercise 18

Sales at will 3

Transactions with no price 0

Shares from compensation/vesting 203,459

History held since 21 Sep 2016